Next-Generation Vaccine Development: mRNA, Viral Vector, and Protein-Based Approaches for Pandemic Preparedness

Earth-wide pandemics have prompted the quick development of vaccines through advanced platforms, including messenger RNA (mRNA) alongside viral vector and protein-based paths of vaccine creation. The investigation of modern vaccine technologies focuses on their operating principles, emphasizing their advantages and restrictions while surveying pandemic readiness functions. The study evaluates the force of artificial intelligence (AI) and bioinformatics to speed up vaccine development processes progressing from target discovery to medical testing phases. This paper examines the adoption of innovative manufacturing technologies that enable quick expansion of production together with distribution capabilities. The document examines ethical matters related to vaccine fairness together with accessibility and public faith. The paper explores how vaccine regulators handle their approvals and emergency authorizations while monitoring market performance to explain difficulties with safety assessment. The review examines recent vaccine technology trends, including the development of universal vaccines, personal immunization, and new vaccine delivery methods. This paper integrates scientific information with regulatory aspects as well as ethical standards to establish a complete comprehension of how vaccines are shaping pandemic preparedness and their developing landscape.